CLINICAL AND INVESTIGATIVE DIFFERENCES (TABULATED)
| Feature / Parameter | Functional Constipation | Hirschsprung Disease (HD) |
|---|---|---|
| Onset of Symptoms | Beyond 1-2 years of age; often coincides with toilet training, dietary transitions, or school entry. | Within infancy; typically presents at birth. |
| Passage of Meconium | Normal (within 48 hours of birth). | Delayed (>48 hours). |
| Encopresis / Soiling | Very common; indicates overflow incontinence. | Rare or absent. |
| Stool Withholding Behavior | Present; common (retentive posturing, tip-toeing, gluteal clenching). | Absent. |
| Stool Characteristics | Large-caliber stools; small liquid smears. | Thin, ribbon-like, or small pellet stools. |
| Episodes of Enterocolitis | Never / No. | Possible / Yes (manifests as foul-smelling diarrhea, fever, sepsis). |
| Growth Failure / Malnutrition | No; extremely rare. | Yes; common complication. |
| Obstructive Symptoms | Rare. | Common (bilious emesis, massive abdominal distension). |
| Abdominal Examination | Not distinctly distended; palpable fecoliths commonly present in lower quadrants. | Markedly distended, tympanitic abdomen. |
| Digital Rectal Examination | Soft to hard impacted stools present in enlarged rectal vault. | Empty rectal vault; tight anal canal; explosive gush of liquid stool/gas upon finger withdrawal (squirt sign). |
| Barium Enema Findings | Rectum larger than sigmoid (ratio >1); massive stool amounts; transition zone absent. | Rectosigmoid ratio <1; clear transition zone seen; delayed contrast evacuation (>24 hr). |
| Anorectal Manometry | Rectoanal inhibitory reflex (RAIR) present (internal sphincter relaxes normally). | RAIR absent (internal sphincter fails to relax upon balloon distension). |
| Rectal Biopsy | Normal ganglion cells present; normal acetylcholinesterase (AChE) activity. | Ganglion cells absent; hypertrophic nerve trunks; increased AChE staining; loss of calretinin. |
PATHOPHYSIOLOGY
Functional Constipation
- Trigger: Initiated by painful defecation (e.g., anal fissure, hard stool passage).
- Behavioral Response: Voluntary or subconscious stool withholding to avoid anticipated pain.
- Rectal Changes: Chronic fecal retention induces increased rectal compliance and megarectum formation.
- Sensory Attenuation: Progressive desensitization of rectal stretch receptors diminishes physiological urge to defecate.
- Result: Proximal liquid colonic contents percolate around hard distal impaction causing unperceived overflow incontinence (encopresis).
Hirschsprung Disease (HD)
- Embryology: Arrest of craniocaudal migration of vagal neural crest cells in hindgut (5th-12th week of gestation).
- Histology: Complete absence of intrinsic ganglion cells in submucosal (Meissner) and myenteric (Auerbach) plexuses.
- Motility Defect: Lack of non-adrenergic, non-cholinergic inhibitory innervation causes tonic contraction of affected aganglionic segment.
- Sphincter Function: Failure of internal anal sphincter relaxation upon rectal distension.
- Result: Functional intestinal obstruction; progressive secondary dilation of proximal normally-innervated bowel.
EVALUATION PROTOCOL
Diagnostic Modalities
- Clinical Diagnosis: Functional constipation diagnosed via Rome IV criteria (≥2 defining symptoms for 1 month). Digital rectal examination unnecessary if criteria met without alarm signs.
- Anorectal Manometry (ARM): Screens for RAIR. Presence excludes HD; absence mandates biopsy.
- Barium Enema: Identifies radiographic transition zone in HD. Avoid prior bowel preparation/cleansing to prevent transient dilation of aganglionic segment.
- Rectal Suction Biopsy: Gold standard for HD diagnosis. Requires 2-3 full-thickness or adequate submucosal samples taken ≥2 cm above dentate line (avoids physiological hypoganglionic zone).
- Histochemical Staining: Acetylcholinesterase (AChE) highlights hypertrophic nerve fibers; Calretinin immunostaining lost in aganglionic segment.
MANAGEMENT PRINCIPLES
Functional Constipation
- Disimpaction: Mandatory initial step prior to maintenance. Oral high-dose Polyethylene Glycol (PEG 3350) or rectal enemas utilized.
- Maintenance Pharmacotherapy: Osmotic laxatives (PEG 3350, lactulose); promotes regular, painless, soft daily stools.
- Behavioral Modification: Post-prandial toilet sitting (5-10 minutes utilizing gastrocolic reflex); positive reinforcement reward systems; demystification.
- Dietary Intervention: Age-appropriate normal fluid and fiber intake.
Hirschsprung Disease
- Initial Stabilization: Rectal irrigations, nasogastric decompression, intravenous fluid resuscitation; broad-spectrum antibiotics mandatory if enterocolitis suspected.
- Surgical Intervention: Definitive treatment. Resection of aganglionic segment; primary pull-through and end-to-end anastomosis of normally innervated ganglionic bowel to anal margin.
- Staged Procedure: Initial diverting colostomy creation followed by delayed pull-through required in cases of severe proximal bowel dilation, active enterocolitis, or extreme prematurity.